Advanced search
Publication Cover
Drug Delivery Volume 24, 2017 - Issue 1
Submit an article Journal homepage
3,071
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Improving anti-tumor activity of sorafenib tosylate by lipid- and polymer-coated nanomatrix

Yang Guo1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and
,
Ting Zhong1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and
,
Xiao-Chuan Duan1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and
,
Shuang Zhang1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and
,
Xin Yao1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and
,
Yi-Fan Yin1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and
,
Dan Huang1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and
,
Wei Ren1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and
,
Qiang Zhang1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and ;3 State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, China
&
Xuan Zhang1 Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing, China, ;2 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China, and Correspondence[email protected]
 show all
Pages 270-277 | Received 25 Aug 2016, Accepted 03 Oct 2016, Published online: 06 Feb 2017

Related Research Data

Bioavailability and pharmacokinetics of sorafenib suspension, nanoparticles and nanomatrix for oral administration to rat
Source: Elsevier BV
The use of lipid-coated nanodiamond to improve bioavailability and efficacy of sorafenib in resisting metastasis of gastric cancer.
Source: Elsevier BV
Understanding the Behavior of Amorphous Pharmaceutical Systems during Dissolution
Source: Springer Science and Business Media LLC
Clinical pharmacokinetics of tyrosine kinase inhibitors.
Source: Elsevier BV
A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate
Source: Elsevier BV
Impact of Polymers on the Crystallization and Phase Transition Kinetics of Amorphous Nifedipine during Dissolution in Aqueous Media
Source: American Chemical Society (ACS)
Effect of polymers and media type on extending the dissolution of amorphous pioglitazone and inhibiting the recrystallization from a supersaturated state.
Source: Informa UK Limited
Oral formulation strategies to improve solubility of poorly water-soluble drugs.
Source: Informa Healthcare
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
Source: Springer Science and Business Media LLC
Sorafenib: 10 years after the first pivotal trial.
Source: Future Medicine Ltd
Target delivery and controlled release of the chemopreventive drug sulindac by using an advanced layered double hydroxide nanomatrix formulation system
Source: (:unav)
Mesoporous systems for poorly soluble drugs
Source: Elsevier BV
BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis
Source: American Association for Cancer Research (AACR)
Highly ordered mesoporous carbon nanomatrix as a new approach to improve the oral absorption of the water-insoluble drug, simvastatin
Source: Elsevier BV
Sylysia 350/Eudragit S100 solid nanomatrix as a promising system for oral delivery of cyclosporine A
Source: Elsevier BV

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.